Connect with us

Hi, what are you looking for?

Smart Success StrategySmart Success Strategy

Editor's Pick

Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis

Phase 2b study evaluating diagnostic performance of 18F-RAD101 for suspected recurrent brain metastases from solid tumors of different origins Underscores Radiopharm’s commitment to developing...

7 hours ago

Editor's Pick

Heliostar Delivers Strong First Quarter 2025 Results

Q1 2025 Operational and Financial Highlights Gold equivalent ounce (‘GEO’) production of 9,082 GEOs and sales of 8,034 GEOs for Q1 2025. The Company...

9 hours ago

Editor's Pick

Element79 Corporate Financing Update

(TheNewswire) VANCOUVER, BC The N ewswire November 25, 2024 Element79 Gold Corp. (CSE: ELEM) (OTC: ELMGF) (FSE: 7YS) (‘Element79’, or the ‘Company ‘) Pursuant...

November 26, 2024
More Posts
Enter Your Information Below To Receive Latest News, And Articles.



    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Disclaimer: smartsuccessstrategy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartsuccessstrategy.com